These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 11431171)
21. Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307. Krauss GL; Perucca E; Ben-Menachem E; Kwan P; Shih JJ; Squillacote D; Yang H; Gee M; Zhu J; Laurenza A Epilepsia; 2013 Jan; 54(1):126-34. PubMed ID: 22905878 [TBL] [Abstract][Full Text] [Related]
22. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy. Shinnar S; Pellock JM; Conry JA Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174 [TBL] [Abstract][Full Text] [Related]
23. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011 [TBL] [Abstract][Full Text] [Related]
24. Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures. Elger C; Bialer M; Cramer JA; Maia J; Almeida L; Soares-da-Silva P Epilepsia; 2007 Mar; 48(3):497-504. PubMed ID: 17319919 [TBL] [Abstract][Full Text] [Related]
25. Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial. Uthman BM; Rowan AJ; Ahmann PA; Leppik IE; Schachter SC; Sommerville KW; Shu V Arch Neurol; 1998 Jan; 55(1):56-62. PubMed ID: 9443711 [TBL] [Abstract][Full Text] [Related]
26. Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial. Lee BI; Yi S; Hong SB; Kim MK; Lee SA; Lee SK; Shin DJ; Kim JM; Song HK; Heo K; Lowe W; Leon T Epilepsia; 2009 Mar; 50(3):464-74. PubMed ID: 19222545 [TBL] [Abstract][Full Text] [Related]
27. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures. Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175 [TBL] [Abstract][Full Text] [Related]
28. Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study. Hufnagel A; Ben-Menachem E; Gabbai AA; Falcão A; Almeida L; Soares-da-Silva P Epilepsy Res; 2013 Feb; 103(2-3):262-9. PubMed ID: 22871333 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures. Xiao Z; Li JM; Wang XF; Xiao F; Xi ZQ; Lv Y; Sun HB Eur Neurol; 2009; 61(4):233-9. PubMed ID: 19176965 [TBL] [Abstract][Full Text] [Related]